1982
DOI: 10.1016/0165-1838(82)90023-6
|View full text |Cite
|
Sign up to set email alerts
|

The regulation of cyclic nucleotides in a sympathetic ganglion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

1984
1984
1993
1993

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(3 citation statements)
references
References 18 publications
0
3
0
Order By: Relevance
“…Ip et al (16) Hz. Immediately after stimulation, the ganglia were homogenized in 3%c trichloroacetic acid and the precipitated material was subjected to two-dimensional gel electrophoresis (25) (29,30), and agents that raise cAMP levels in the ganglion can cause activation and phosphorylation of tyrosine hydroxylase (20,21). Several peptides, including vasoactive intestinal peptide and secretin, also increase the content of cAMP in the ganglion (20,31 Preganglionic nerve stimulation increased the phosphorylation of at least six proteins other than tyrosine hydroxylase in the SCG.…”
Section: Discussionmentioning
confidence: 99%
“…Ip et al (16) Hz. Immediately after stimulation, the ganglia were homogenized in 3%c trichloroacetic acid and the precipitated material was subjected to two-dimensional gel electrophoresis (25) (29,30), and agents that raise cAMP levels in the ganglion can cause activation and phosphorylation of tyrosine hydroxylase (20,21). Several peptides, including vasoactive intestinal peptide and secretin, also increase the content of cAMP in the ganglion (20,31 Preganglionic nerve stimulation increased the phosphorylation of at least six proteins other than tyrosine hydroxylase in the SCG.…”
Section: Discussionmentioning
confidence: 99%
“…Regulation by cyclic AMP Both preganglionic tetani and isoprenaline increase cyclic AMP levels in the ganglion (Briggs et al, 1982;Volle et al, 1982), potentiate nicotinic transmission, and potentiate evoked ACh release. We therefore tested the hypothesis that cyclic AMP mediates l.t.p.…”
Section: Receptor-mediated Regulationmentioning
confidence: 99%
“…The idea that cyclic AMP may mediate the 3-adrenoceptor-induced potentiation of nicotinic transmission is prompted by several findings: (1) P-adrenoceptor agonists stimulate cyclic AMP synthesis potently and efficaciously in the whole sympathetic ganglion (Briggs et al, 1982;Volle et al, 1982); (2) preganglionic denervation reduces the amount of cyclic AMP formed following exposure to ,-adrenoceptor agonists (Quenzer et al, 1980); (3) P-adrenoceptor agonists and cyclic AMP both increase the quantal content of nicotinic transmission in the frog sympathetic ganglion (Kuba & Kumamoto, 1986), and both increase nicotinic transmission and evoked ACh release in the rat sympathetic ganglion (this study). However, other evidence indicates that Padrenoceptor agonists may also act postsynaptically in the sympathetic ganglion (Brown & Dunn, 1983a), and that the potentiation is not mediated by cyclic AMP (Brown & Dunn, 1983b (Lynch & Baudry, 1984;Stanton & Sarvey, 1985a,b;Akers et al, 1986;Malenka et al, 1986), there is persuasive evidence in Aplysia that cyclic AMP mediates a longlasting presynaptic potentiation through inhibition of K+ channels (Kandel & Schwartz, 1982;Abrams et al, 1984;Schuster et al, 1985;Walters & Byrne, 1985; cf.…”
Section: Receptor-mediated Regulationmentioning
confidence: 99%